Hit It With Your Best Shot- The Case for IO in Early-Stage NSCLC in a Once in a Lifetime World


Episode Artwork
1.0x
0% played 00:00 00:00
Dec 01 2024 27 mins   3
Our latest podcast explores the case for IO in early-stage NSCLC in our once in a lifetime world – the current Australian context. We review the medical oncology and surgical perspective of the current evidence for clinical benefit and what we have available in Australia. As clinicians, we are trained to give our best treatment up front, so patient discussion is important in an environment where we can only prescribe IO therapy once during the patient’s lung cancer disease.

Dr Deme Karikios, Medical Oncologist from Nepean Hospital and Co-Chair of the Oncology Drugs Working Group is joined by Dr Lauren Brown, Medical Oncologist and Research Fellow at Nepean, Blacktown & Westmead Hospitals and Dr Stephen Barnett, Cardiothoracic Surgeon at the Austin Hospital, Peter MacCallum, Royal Melbourne and Western General Hospitals.


CheckMate816: https://www.nejm.org/doi/full/10.1056/NEJMoa2202170

IMpower010: https://www.annalsofoncology.org/article/S0923-7534(23)00764-0/fulltext

Neotorch: https://jamanetwork.com/journals/jama/fullarticle/2813880

Keynote671: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01756-2/abstract

AGEAN: https://www.nejm.org/doi/full/10.1056/NEJMoa2304875

CheckMate770: https://www.nejm.org/doi/full/10.1056/NEJMoa2311926